You should also not take an MAOI within 2 weeks of stopping Lexapro or start Lexapro if you stopped taking an MAOI in the last 2 weeks unless directed by your healthcare provider
Garca-CasaresN,JorgeRE,Garca-ArnsJA,AcionL,BerthierML,Gonzalez-AlegreP,NabrozidisA,GutirrezA,ArizaMJ,RiojaJ,Gonzlez-SantosP.Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study.J Alzheimers Dis.2014;42(4):1337-46
Comparing GLP-1 Agonists and Traditional Methods Effectiveness: GLP-1 agonists : Clinical studies have demonstrated that GLP-1 medications can lead to rapid and substantial weight loss, with participants losing an average of 15-20% of their body weight over 12-16 months
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a partial sequence found in human gastric juice, studied in preclinical models for tissue-repair and gut-mucosal signaling pathways